HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal rhabdomyoma causing right ventricular inflow obstruction with duct-dependent pulmonary blood flow: successful stenting of PDA.

Abstract
We describe an infant with the antenatal diagnosis of a large intracardiac rhabdomyoma causing tricuspid inflow obstruction. Postnatal cyanosis and arterial hypoxemia prompted commencement of intravenous prostaglandin E1 with immediate improvement in saturations. Clinical and genetic testing confirmed diagnosis of tuberous sclerosis. To secure ductal patency, two tandem coronary stents were implanted via an antegrade approach. Several episodes of long RP atrio-ventricular re-entrant tachycardia were observed. At 7(1/2) months of age, the tumor was no longer obstructive to tricuspid inflow, ductal flow was highly restrictive and there was no recurrence of supraventricular tachycardia.
AuthorsMaria V Ilina, Edgar T Jaeggi, Kyong-Jin Lee
JournalCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (Catheter Cardiovasc Interv) Vol. 69 Issue 6 Pg. 881-5 (May 01 2007) ISSN: 1522-1946 [Print] United States
PMID17436271 (Publication Type: Case Reports, Journal Article)
Copyright(c) 2007 Wiley-Liss, Inc.
Topics
  • Adult
  • Cardiac Catheterization
  • Coronary Angiography
  • Ductus Arteriosus, Patent (complications, diagnosis, physiopathology, therapy)
  • Echocardiography, Doppler, Color
  • Electrocardiography
  • Female
  • Genetic Testing
  • Heart Neoplasms (complications, diagnosis, genetics, physiopathology)
  • Humans
  • Infant, Newborn
  • Live Birth
  • Prenatal Diagnosis
  • Pulmonary Circulation
  • Radiography, Interventional
  • Rhabdomyoma (complications, diagnosis, genetics, physiopathology)
  • Stents
  • Treatment Outcome
  • Tuberous Sclerosis (complications, diagnosis, genetics, physiopathology)
  • Ventricular Outflow Obstruction (etiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: